These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30942881)

  • 61. Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral Suppression.
    Zhang HL; Mock M; Bushman L; Anderson PL; Kiser JJ; Naggie S
    Clin Infect Dis; 2024 Sep; 79(3):705-708. PubMed ID: 38703389
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis.
    Nicol MR; Eneh P; Nakalega R; Kaiser T; Kabwigu S; Isingel E; Beksinska M; Sykes C; Fowler MG; Brown TT; Staley C; Kiweewa Matovu F
    Clin Infect Dis; 2020 Apr; 70(8):1717-1724. PubMed ID: 31131846
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.
    Kiser JJ; Fletcher CV; Flynn PM; Cunningham CK; Wilson CM; Kapogiannis BG; Major-Wilson H; Viani RM; Liu NX; Muenz LR; Harris DR; Havens PL;
    Antimicrob Agents Chemother; 2008 Feb; 52(2):631-7. PubMed ID: 18025112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens.
    van Zyl G; Jennings L; Kellermann T; Nkantsu Z; Cogill D; van Schalkwyk M; Spinelli M; Decloedt E; Orrell C; Gandhi M
    AIDS; 2022 Nov; 36(14):2057-2062. PubMed ID: 36305182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings.
    Jennings L; Kellermann T; Spinelli M; Nkantsu Z; Cogill D; van Schalkwyk M; Decloedt E; van Zyl G; Orrell C; Gandhi M
    AIDS Res Hum Retroviruses; 2022 Jun; 38(6):455-462. PubMed ID: 34779228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection.
    Bae J; Tantawy M; Gong Y; Langaee T; Lartey M; Ganu V; Tachi K; Ojewale O; Obo-Akwa A; Boamah I; Bushman LR; Ellison L; Yang H; Anderson PL; Kwara A
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0054924. PubMed ID: 39078131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients.
    Goicoechea M; Jain S; Bi L; Kemper C; Daar ES; Diamond C; Ha B; Flaherty J; Sun S; Richman D; Louie S; Haubrich R;
    AIDS; 2010 Mar; 24(5):707-16. PubMed ID: 20087154
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Income Inequality Is Associated With Low Cumulative Antiretroviral Adherence in Persons With Human Immunodeficiency Virus.
    Vernon F; Morrow M; MaWhinney S; Coyle R; Coleman S; Ellison L; Zheng JH; Bushman L; Kiser JJ; Galárraga O; Anderson PL; Castillo-Mancilla J
    Open Forum Infect Dis; 2020 Oct; 7(10):ofaa391. PubMed ID: 33072812
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparing a point-of-care urine tenofovir lateral flow assay to self-reported adherence and their associations with viral load suppression among adults on antiretroviral therapy.
    Phillips T; Gomba Y; Myer L
    Trop Med Int Health; 2024 Feb; 29(2):96-103. PubMed ID: 38084797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.
    Mills A; Arribas JR; Andrade-Villanueva J; DiPerri G; Van Lunzen J; Koenig E; Elion R; Cavassini M; Madruga JV; Brunetta J; Shamblaw D; DeJesus E; Orkin C; Wohl DA; Brar I; Stephens JL; Girard PM; Huhn G; Plummer A; Liu YP; Cheng AK; McCallister S;
    Lancet Infect Dis; 2016 Jan; 16(1):43-52. PubMed ID: 26538525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIV.
    Hirsh ML; Edwards JA; Robichaux C; Brijkumar J; Moosa MS; Ofotokun I; Johnson BA; Pillay S; Pillay M; Moodley P; Sun YV; Liu C; Dudgeon MR; Ordoñez C; Kuritzkes DR; Sunpath H; Morrow M; Anderson PL; Ellison L; Bushman LR; Marconi VC; Castillo-Mancilla JR
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad360. PubMed ID: 37469618
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug Concentrations in Hair and Dried Blood Spots as Preexposure Prophylaxis Adherence Metrics During Pregnancy and Postpartum.
    Wu L; Kinuthia J; Anderson PL; Baeten JM; Dettinger JC; Gandhi M; Gomez L; John-Stewart G; Marwa MM; Ngumbau N; Otieno F; Omondi P; Odhiambo B; Watoyi S; Pintye J
    J Infect Dis; 2024 Sep; 230(3):689-695. PubMed ID: 38700101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Establishment of intracellular tenofovir-diphosphate as the key determinant for in vitro-in vivo translation of antiviral efficacy.
    Ma B; Barth A; McHale CM; Lai MT
    Antiviral Res; 2018 Mar; 151():1-3. PubMed ID: 29337165
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2).
    Hirt D; Ekouévi DK; Pruvost A; Urien S; Arrivé E; Blanche S; Avit D; Amani-Bosse C; Nyati M; Legote S; Ek ML; Say L; McIntyre J; Dabis F; Tréluyer JM
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2961-7. PubMed ID: 21464249
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.
    Duwal S; Schütte C; von Kleist M
    PLoS One; 2012; 7(7):e40382. PubMed ID: 22808148
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V.
    Margot N; Ram R; Abram M; Haubrich R; Callebaut C
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988104
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
    Hawkins T; Veikley W; Durand-Gasselin L; Babusis D; Reddy YS; Flaherty JF; Ray AS
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1549-55. PubMed ID: 21282432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
    Matthews LT; Atukunda EC; Owembabazi M; Kalyebera KP; Psaros C; Chitneni P; Hendrix CW; Marzinke MA; Anderson PL; Isehunwa OO; Hurwitz KE; Bennett K; Muyindike W; Bangsberg DR; Haberer JE; Marrazzo JM; Bwana MB
    PLoS Med; 2023 Feb; 20(2):e1004088. PubMed ID: 36795763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation.
    Dickinson L; Yapa HM; Jackson A; Moyle G; Else L; Amara A; Khoo S; Back D; Karolia Z; Higgs C; Boffito M
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6080-6. PubMed ID: 26195515
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adults.
    Baheti G; King JR; Acosta EP; Fletcher CV
    AIDS; 2013 Jan; 27(2):221-5. PubMed ID: 23032419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.